Samsung Bioepis

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about
Samsung Bioepis, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Samsung Bioepis please access Flcube.com

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Samsung Bioepis, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Samsung Bioepis please access Flcube.com

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody
CompanyDeals

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody

BioPartners X announced that it has entered into a technology transfer agreement with the Hospital of Dermatology, Chinese Academy of Medical Sciences (CAMS) for an innovative CD132‑targeting monoclonal antibody, with…

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Samsung Bioepis Expands Sandoz Partnership – Global Deal for Five Biosimilars Including Entyvio Copycat SB36

Samsung Bioepis Announces Global ADC Collaboration with Phrontline Biopharma to Advance TJ108
CompanyDeals

Samsung Bioepis Announces Global ADC Collaboration with Phrontline Biopharma to Advance TJ108

Sandoz Launches Pyzchiva Biosimilar of J&J's Stelara in US
CompanyDrug

Sandoz Launches Pyzchiva Biosimilar of J&J’s Stelara in US

Samsung Bioepis' Ospomyv and Xbryk Gain FDA Approval for RANKL Inhibitor Biosimilars
CompanyDrug

Samsung Bioepis’ Ospomyv and Xbryk Gain FDA Approval for RANKL Inhibitor Biosimilars

Samsung Bioepis and Teva Partner on Biosimilar EPYLLI for US Market
CompanyDeals

Samsung Bioepis and Teva Partner on Biosimilar EPYLLI for US Market

Biogen and Samsung Bioepis Win EC Approval for Opuviz Biosimilar in Europe
CompanyDrug

Biogen and Samsung Bioepis Win EC Approval for Opuviz Biosimilar in Europe

CompanyDeals

Sandoz Inks Deal with Samsung Bioepis for Ustekinumab Biosimilar SB17